COMMUNIQUÉS West-GlobeNewswire

Sunesis Pharmaceuticals Appoints William Quinn as Chief Financial Officer and Senior Vice President, Finance and Corporate Development

30/11/2017 - 13:00

SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced the appointment of William Quinn as Chief Financial Officer and Senior Vice President, Finance [...]

Tonix Pharmaceuticals to Present at 10th Annual LD Micro Investor Conference

30/11/2017 - 13:00

NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a company in Phase 3 development of Tonmya®* (cyclobenzaprine HCI sublingual tablets), or TNX-102 SL, a U.S. Food [...]

Mpx Reports Q2 Fiscal 2018 Results

30/11/2017 - 13:00

TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- (CSE: MPX) (OTCQB:MPXEF) MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) reports financial results for its second quarter of fiscal 2018, ended [...]

Merus Announces Third Quarter 2017 Financial Results and Clinical Highlights

30/11/2017 - 13:00

UTRECHT, The Netherlands, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics ® ), today announced [...]

Emergent BioSolutions to Host 2017 Analyst & Investor Day

30/11/2017 - 13:00

GAITHERSBURG, Md., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced that the company will host an analyst and investor day on December 7, 2017 in New York City. This event, which [...]

Nabriva Therapeutics to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference

30/11/2017 - 13:00

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical-stage biopharmaceutical company engaged in the research and development of novel anti- [...]

Purepoint Uranium Group Inc. Raises Ceiling for Private Placement

30/11/2017 - 12:45

TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (TSXV:PTU) (the “Company”) announced its intention to raise the ceiling for the previously announced non-brokered private placement (the “Private [...]

ALK secures pricing and reimbursement for ACARIZAX® in France

30/11/2017 - 12:27

Copenhagen, 2017-11-30 12:27 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that it has reached a satisfactory agreement with health authorities in France for the pricing and [...]

Total number of shares and voting rights in Zealand at November 30, 2017

30/11/2017 - 11:13

Company announcement - No. 53 / 2017 Total number of shares and voting rights in Zealand at November 30, 2017 Copenhagen, November 30, 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' [...]

About Board Membership of Mr. Salvis Lapins

30/11/2017 - 10:55

Olaine, 2017-11-30 10:55 CET (GLOBE NEWSWIRE) -- AS Olainfarm hereby informs that upon mutual agreement Mr. Salvis Lapins will resign from position of the Board Member by January 12, 2018. Information prepared by: [...]

Top Facial Plastic Surgeon Releases Book for Baby Boomer Women on How to Look Young Again

30/11/2017 - 10:00

NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- According to the American Society of Aesthetic Plastic Surgery, in just the last two decades, the number of cosmetic procedures performed on patients over the age of 65 has [...]

K2M Announces Completion of 300 RHINE™ Cervical Disc System Surgical Cases

30/11/2017 - 10:00

LEESBURG, Va., Nov. 30, 2017 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Financial calendar for Zealand Pharma in 2018

30/11/2017 - 09:08

Company announcement - No. 52/2017 Financial calendar for Zealand Pharma in 2018 Copenhagen, November 30, 2017 - Zealand Pharma A/S ("ZEAL") announces the following dates for the company's planned financial reporting in [...]

CORRECTION: Probiodrug AG: Probiodrug reports Third Quarter 2017 Business Update

30/11/2017 - 08:14

This is a correction of the announcement from 06:00 30.11.2017 GMT. Reason for the correction: > As of 30 September 2017, Probiodrug held EUR 11.70 million in cash and cash equivalents, providing according to present [...]

Elias Zerhouni, President of Sanofi R&D, wins 'Executive of the Year' at annual Scrip Awards

30/11/2017 - 07:56

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Elias Zerhouni, President of Sanofi R&D, wins 'Executive of the Year' at annual Scrip Awards · Dr. Zerhouni credited with transforming Sanofi's R&D into a [...]

Elias Zerhouni, Président Monde de la R&D de Sanofi, nommé « Executive of the Year » aux Scrip Awards

30/11/2017 - 07:56

Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Elias Zerhouni, Président Monde de la R&D de Sanofi, nommé « Executive of the Year » aux Scrip Awards Cette distinction reconnaît le rôle joué par le [...]

Novartis' Cosentyx® is first biologic to show long-term efficacy in nail and palmoplantar psoriasis, which can impact up to 90% of psoriasis patients

30/11/2017 - 07:16

Unique Cosentyx ® (secukinumab) data reinforce treatment option for up to 90% of psoriasis patients who may develop nail or palmoplantar psoriasis[1] - [4] Cosentyx results represent the first data on biologic use for [...]

Probiodrug AG: Probiodrug reports Third Quarter 2017 Business Update

30/11/2017 - 07:00

HALLE (SAALE), Germany, 30 November 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), today announces its third quarter [...]

3D Signatures Reports First Quarter Financial Results for Fiscal 2018

30/11/2017 - 01:12

TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based on the three- [...]